These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2247484)

  • 1. Biology of residual breast cancer after therapy: a kinetic interpretation.
    Norton L
    Prog Clin Biol Res; 1990; 354A():109-32. PubMed ID: 2247484
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of multimodality therapy in the management of locally advanced carcinoma of the breast.
    Heys SD; Eremin JM; Sarkar TK; Hutcheon AW; Ah-See A; Eremin O
    J Am Coll Surg; 1994 Oct; 179(4):493-504. PubMed ID: 7921405
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on kinetics and biology of the residual cancer, and on relevant therapeutic strategies based on these phenomena.
    Ragaz J
    Prog Clin Biol Res; 1990; 354B():117-39. PubMed ID: 2236161
    [No Abstract]   [Full Text] [Related]  

  • 4. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
    Bar MH
    Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer.
    Ring A; Harper-Wynne C; Smith I
    Cancer Chemother Biol Response Modif; 2005; 22():545-61. PubMed ID: 16110628
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interdependence of laboratory and clinical research in the study of metastases.
    Fisher B
    Symp Fundam Cancer Res; 1983; 36():27-46. PubMed ID: 6382508
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on PBT-1 study of high-dose consolidation versus standard therapy in metastatic breast cancer.
    Livingston R; Crowley J
    J Clin Oncol; 1999 Nov; 17(11 Suppl):22-4. PubMed ID: 10630257
    [No Abstract]   [Full Text] [Related]  

  • 9. [-Adjuvant systemic therapy of breast carcinoma-].
    Goldhirsch A; Castiglione-Gertsch M
    Arch Gynecol Obstet; 1995; 256 Suppl():S93-103. PubMed ID: 8619668
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.
    Chen AM; Meric-Bernstam F; Hunt KK; Thames HD; Oswald MJ; Outlaw ED; Strom EA; McNeese MD; Kuerer HM; Ross MI; Singletary SE; Ames FC; Feig BW; Sahin AA; Perkins GH; Schechter NR; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Jun; 22(12):2303-12. PubMed ID: 15197191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials referral resource. New autologous stem-cell transplant protocols.
    Cheson BD; Phillips PH
    Oncology (Williston Park); 1997 Feb; 11(2):178-80. PubMed ID: 9057174
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in breast cancer.
    Charfare H; Limongelli S; Purushotham AD
    Br J Surg; 2005 Jan; 92(1):14-23. PubMed ID: 15635596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
    Smith GA; Henderson IC
    Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of the new biology for therapy in breast cancer.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials referral resource. Metastatic breast cancer.
    Cheson BD; Phillips PH; Abrams JS
    Oncology (Williston Park); 1993 Dec; 7(12):43-4, 46. PubMed ID: 8292506
    [No Abstract]   [Full Text] [Related]  

  • 17. A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant.
    Nieto Y; Cagnoni PJ; Shpall EJ; Xu X; Murphy J; Vredenburgh J; Chao NJ; Bearman SI; Jones RB
    Clin Cancer Res; 1999 Nov; 5(11):3425-31. PubMed ID: 10589754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer.
    Valagussa P; Bonadonna G
    Cancer Chemother Biol Response Modif; 2001; 19():597-628. PubMed ID: 11686035
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
    Conrad B; Kieser R
    Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.